Consiglio di amministrazione

Bret Field, Esq.

DIRECTOR / SHAREHOLDER

Mr. Field is a founding partner of Bozicevic, Field & Francis LLP, founded in 1997. BFF is a healthcare- patent law firm focused on building IP portfolios for start-ups, large companies, and academic institutions.

Tom Gadek, PhD

DIRECTOR / SHAREHOLDER

Dr. Gadek has 40 years Biotech/Biopharma leadership experience, including 15+ years at Genentech in the Department of Bioorganic Chemistry, Co-founder of MCAL Therapeutics, CEO & President Tear Solutions, Founder & CEO of Rogne Bioscience, Founder & CEO of SARcode which discovered and developed Xiidra. Xiidra was acquired by Novartis in 2019 for $3.5B.

Winfried Kuhlmann, PhD

DIRECTOR / SHAREHOLDER

Dr. Kuhlmann has over thirty-five years international Life Sciences/Biopharma experience. He has been the principal advisor to large and mid-cap global biopharma and bioengineering companies and has held various senior management positions including Managing Director of Xcellerex GmbH, Managing Director of zeta Bio-und Verfahrenstechnik GmbH, and Managing Director of B. Braun Biotech International GmbH.

Glen March, MD

DIRECTOR, SHAREHOLDER, LSC STRATEGIC ALLIANCES

Dr. March is an ophthalmologist with training in Neuro-Ophthalmology at Harvard Medical School and Orbital and Ophthalmic Plastic Surgery at UCLA. He co-founded March Vision Care. He functioned as Chairman and CEO until its sale to United Healthcare. He is co-principal at Strategem Investments, LLC, a private equity firm. He serves as Vice Chairman of Amicrobe, Inc.

Ms. Zari Mansouri

FOUNDER / CEO / CHAIRWOMAN / SHAREHOLDER

Zari Mansouri is the CEO and Founder of. LSC and has served in this position since its inception. She has 25 years of industry experience as a scientist, product marketer, and innovator. Zari is also the inventor of over 100 issued and pending global patent applications in the areas of dermal delivery, innovative bioactives for therapeutic & preventive dermal applications, antimicrobial products, UVA/UVB balanced sunscreens, topical anti-acne, scar treatment and other applications.

ADVISORS TO LSC BOARD & MANAGEMENT

Robert Bianchini, PhD

INDEPENDENT ADVISOR / SHAREHOLDER

Dr. Bianchini has over thirty years industry experience in various leadership roles across all facets of the consumer product, pharmaceutical, and chemical industries. He served as an executive at Rodan and Fields, Johnson and Johnson, Merck and Co., and other companies.

Ross Macdonald, PhD

INDEPENDENT ADVISOR TO LSC BOD/MANAGEMENT, HEAD OF BUSINESS DEVELOPMENT (PHARMA DIVISION)

Dr. Macdonald is a senior pharmaceutical industry executive with thirty-three years international experience in dermatology and drug delivery. Has held senior level management positions in M&A, BD&L and general management with large and mid-cap global pharma and biotech companies, including Sinclair Pharmaceuticals Ltd, Stiefel Laboratories, Inc., Connetics Corporation, FH Faulding, and other companies.

it_ITItalian